The American Journal of Managed Care

First Non-INSTI, Tenofovir-Free Regimen DOR/ISL Gains FDA Approval for HIV

FDA approves doravirine/islatravir, a once-daily, 2-drug, single-tablet HIV regimen showing noninferior efficacy to standard ...
The American Journal of Managed Care

More Focus Needed on Prescribing Disparities for INSTI HIV Treatment

Data from 2 patient cohorts show that by increasing awareness of such influences as clinic location and patient age and transgender status, gaps in prescription decisions for integrase strand transfer ...
Healio

Diabetes risk increased among people with HIV on INSTI-based ART

Please provide your email address to receive an email when new articles are posted on . O’Halloran and colleagues used insurance databases to identify adults with HIV who had newly initiated ART ...
Yahoo Finance

HIV Self-Testing Just Got Faster: FDA Approves the 1-Minute INSTI® HIV Self Test

The INSTI ® HIV Self Test delivers highly accurate results in 60 seconds or less, the fastest home-use HIV rapid test available. FDA-approved and ready for U.S. consumers, providing a private and ...
Newswire

INSTI HIV Self Test Receives Global Fund Classification for Procurement

RICHMOND, BC, July 6, 2017 /CNW/ - bioLytical Laboratories, a world leader in rapid infectious disease tests, is pleased to announce that its INSTI HIV Self Test has been designated by the Global Fund ...